Source:http://linkedlifedata.com/resource/pubmed/id/14747383
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-1-28
|
pubmed:abstractText |
The p38 mitogen-activated protein kinase (MAPK) pathway transduces external stress stimuli and is important in extracellular matrix synthesis in cell types in vitro; however, its role in renal fibrosis is not known. Explored was the role the p38 MAPK pathway in rat unilateral ureteric obstruction (UUO), a model of renal fibrosis induced by a noninflammatory surgical insult. In a time-course study, a marked increase in phosphorylation (activation) of p38 in both interstitial myofibroblasts and tubules was shown. Rats were then treated daily with a specific inhibitor of p38alpha, NPC 31169, from the time of UUO surgery until being killed 7 d later. Compared with vehicle, NPC 31169-treated rats had a significant reduction in renal fibrosis assessed by interstitial volume, collagen IV deposition, and mRNA levels. This was primarily due to a reduction in the accumulation of interstitial myofibroblasts, as shown by a reduction in the area of immunostaining for alpha-smooth muscle actin and heat shock protein 47. The increase in renal TGF-beta1 mRNA and protein levels in UUO was unaltered with NPC 31169 treatment; however, connective tissue growth factor mRNA was reduced. These results demonstrate that p38alpha MAPK plays an important role in renal fibrosis, acting downstream of TGF-beta1. Blockade of p38 MAPK reduces extracellular matrix production and may be considered a potential therapeutic option in the treatment of renal fibrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1046-6673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
370-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:14747383-Animals,
pubmed-meshheading:14747383-Enzyme Activation,
pubmed-meshheading:14747383-Female,
pubmed-meshheading:14747383-Fibrosis,
pubmed-meshheading:14747383-Kidney,
pubmed-meshheading:14747383-Mitogen-Activated Protein Kinases,
pubmed-meshheading:14747383-Rats,
pubmed-meshheading:14747383-Rats, Sprague-Dawley,
pubmed-meshheading:14747383-Up-Regulation,
pubmed-meshheading:14747383-Ureteral Obstruction,
pubmed-meshheading:14747383-p38 Mitogen-Activated Protein Kinases
|
pubmed:year |
2004
|
pubmed:articleTitle |
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis.
|
pubmed:affiliation |
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia. cosimo.stambe@med.monash.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|